Structure Formula Of Ondansetron (Ondansetron 01)
Ondansetron Injection, Solution
Product Images NDC 67184-0507
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67184-0507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ondansetron Injection Usp Label Image (2mL Single-use Vials)
The text appears to be a label for a medication called Ondansetron Injection USP. It is manufactured by Qilu Pharmaceutical Haman Co., Ltd. in China and contains 4 I2 L Mfd of ondansetron at a concentration of 2 mgImL. The medication is for IM or IV use only and is available in a single-dose vial of 2mL. The label includes information about the lot number and expiration date. It is intended for prescription use only and has a GTIN code.*
Ondansetron Injection Usp Label Image (5 x 2mL Single-use Vials)
ONDANSETRON INJECTION USP is a medication for intramuscular or intravenous use only. It comes in single-dose vials of 2 mL with a concentration of 4 mg/2 mL (2 mg/m). Each 1 mL of the solution contains ondansetron 2 mg, ondansetron hydrochloride dihydrate, sodium chloride 8 mg, citric acid monohydrate 0.5 mg, and sodium citrate dihydrate 0.25 mg. This medication is used for the prevention of nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It is important to keep it in the carton until the time of use. This medication is available by prescription only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
